Re: Additional WarrantsWarrant Agreement • May 8th, 2019 • Wright Medical Group N.V. • Orthopedic, prosthetic & surgical appliances & supplies • New York
Contract Type FiledMay 8th, 2019 Company Industry JurisdictionThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Warrants issued by Wright Medical Group N.V. (“Company”) to JPMorgan Chase Bank, National Association (“Dealer”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements with respect to the Transaction and serve as the final documentation for the Transaction.
JPMorgan Chase Bank, National Association London Branch Canary Wharf London E14 5JP EnglandWarrant Agreement • May 8th, 2019 • Wright Medical Group N.V. • Orthopedic, prosthetic & surgical appliances & supplies • New York
Contract Type FiledMay 8th, 2019 Company Industry JurisdictionThe purpose of this letter agreement (this “Confirmation”) is to confirm the terms and conditions of the Warrants issued by Wright Medical Group N.V. (“Company”) to JPMorgan Chase Bank, National Association (“Dealer”) as of the Trade Date specified below (the “Transaction”). This letter agreement constitutes a “Confirmation” as referred to in the ISDA Master Agreement specified below. This Confirmation shall replace any previous agreements with respect to the Transaction and serve as the final documentation for the Transaction.
PORTIONS HEREIN IDENTIFIED BY [***] HAVE BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE THE EXCLUDED INFORMATION IS BOTH (I) NOT MATERIAL AND (II) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED.] AMENDMENT TO COMMERCIAL SUPPLY...Commercial Supply Agreement • May 8th, 2019 • Wright Medical Group N.V. • Orthopedic, prosthetic & surgical appliances & supplies
Contract Type FiledMay 8th, 2019 Company IndustryThis Amendment to Commercial Supply Agreement (“Amendment”) dated as of January 31, 2019 (“Amendment Effective Date”) between BioMimetic Therapeutics, LLC (“Sponsor”), a Delaware limited liability company and FUJIFILM Diosynth Biotechnologies U.S.A., Inc., a Delaware corporation (“Fujifilm”) (each a “Party”, collectively, the “Parties”).